Showing 241 - 260 results of 66,065 for search '(( 5 ((((non decrease) OR (point decrease))) OR (mean decrease)) ) OR ( 5 c decrease ))', query time: 1.20s Refine Results
  1. 241
  2. 242
  3. 243
  4. 244
  5. 245
  6. 246
  7. 247
  8. 248
  9. 249

    The novel <i>carboxylesterase 1</i> variant c.662A>G may decrease the bioactivation of oseltamivir in humans by Jaeseong Oh (3947381)

    Published 2017
    “…</p><p>Methods</p><p>A single oral dose of oseltamivir at 75 mg was administered to 20 healthy subjects, 8 heterozygous c.662A>G carriers (c.662AG) and 12 non-carriers (c.662AA). …”
  10. 250
  11. 251
  12. 252
  13. 253
  14. 254
  15. 255
  16. 256

    Nimodipine does not decrease markers of neuritic dystrophy in 5XFAD transgenic mice. by Katherine R. Sadleir (12035242)

    Published 2022
    “…Similarly, BACE1, LAMP1 and LC3B-II/ LC3B-I were also increased in nimodipine-treated 5XFAD compared to nimodipine treated non-transgenic mice, indicating that nimodipine did not decrease the accumulation of these dystrophic neurite marker proteins. …”
  17. 257

    Administration of APB5, but not APA5, decreases the hyperplasia of alveolar type 2 epithelial cells induced by BLM. by Masami Kishi (6167105)

    Published 2018
    “…The BLM treatment induced hyperplasia and increased the number of SP-C-positive type 2 epithelial cells. The administration of APB5 markedly decreased the hyperplasia of type 2 epithelial cells induced by BLM. …”
  18. 258

    The 5’SS motif decreases mRNA stability and promotes nuclear retention. by Eliza S. Lee (715538)

    Published 2015
    “…Note that the relative level of <i>c-ftz-Δi-V5-His</i> decreases over the first 60 min until 40–50% of the mRNA remains, after which point the ratio is stable. …”
  19. 259

    Annual number of outpatient visits in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)

    Published 2025
    “…<p>In the recurrence group, mean outpatient visits (± standard deviation) decreased from 13.6 ± 3.0 to 11.9 ± 5.0, 8.1 ± 3.9, and 7.8 ± 3.2 at 1, 2, and 3 years postoperatively, respectively (Kruskal-Wallis test, P < 0.001; Dunn’s test, **P < 0.01). …”
  20. 260